PEN - Penumbra, Inc.
NEXT EARNINGS:
Apr 21, 2026
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$369.91
DETAILS
HIGH:
$388.00
LOW:
$340.00
MEDIAN:
$374.00
CONSENSUS:
$369.91
UPSIDE:
8.93%
Market Cap:
13.32B
Volume:
766,237
Avg Volume:
958,731
52 Week Range:
221.26-362.41
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
0.81
Last Dividend:
$N/A
Exchange:
NYSE
Country:
US
Employees:
4,500
IPO Date:
2015-09-18
EPS (TTM):
0.36
P/E Ratio:
654.78
Revenue (TTM):
1.19B
Total Assets:
1.53B
Total Debt:
223.39M
Cash & Equiv:
324.40M
Rev Growth (5Y):
16.9%
EPS Growth (5Y):
-23.7%
FCF Growth (5Y):
100.5%
ROCE:
1.6%
Debt/Equity:
0.19
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-05 | $0.97 | $0.93 | +4.4% | $354.7M | $341.0M | +4.0% |
| 2025-07-29 | $0.86 | $0.81 | +6.2% | $339.5M | $341.3M | -0.6% |
| 2025-04-23 | $0.83 | $0.66 | +25.8% | $324.1M | $327.3M | -1.0% |
| 2025-02-18 | $0.97 | $0.88 | +10.2% | $315.5M | $311.6M | +1.2% |
| 2024-10-30 | $0.85 | $0.69 | +23.2% | $301.0M | $311.6M | -3.4% |
| 2024-07-30 | $0.64 | $0.56 | +14.3% | $299.4M | $298.4M | +0.3% |
| 2024-05-07 | $0.41 | $0.42 | -2.4% | $278.7M | $274.9M | +1.4% |
| 2024-02-22 | $0.76 | $0.71 | +7.0% | $284.7M | $286.6M | -0.7% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.19B | 1.06B | 847.13M | 747.59M | 560.41M | 547.40M | 444.94M | 333.76M | 263.32M | 186.09M | 125.51M | 88.85M |
| Net Income | 14.01M | 90.95M | (2.00M) | 5.28M | (15.70M) | 48.46M | 6.60M | 4.66M | 14.81M | 2.37M | 2.25M | 4.10M |
| EPS | 0.36 | 2.37 | -0.05 | 0.07 | -0.54 | 1.39 | 0.18 | 0.14 | 0.49 | 0.09 | -0.03 | 0.04 |
| Total Assets | 1.53B | 1.56B | 1.37B | 1.24B | 822.98M | 665.90M | 515.01M | 476.67M | 308.25M | 263.85M | 121.38M | 71.15M |
| Total Debt | 223.39M | 234.34M | 235.77M | 173.55M | 77.28M | 82.30M | 0 | 0 | 0 | 0 | 0 | 6.00M |
| Cash & Equivalents | 324.40M | 167.49M | 69.86M | 59.38M | 69.67M | 72.78M | 67.85M | 50.64M | 13.24M | 19.55M | 3.29M | 4.13M |
| Operating Cash Flow | 168.48M | 97.33M | (55.66M) | 9.50M | (33.24M) | 26.65M | 28.81M | 12.69M | (12.81M) | (22.28M) | (6.39M) | (3.40M) |
| Free Cash Flow | 147.30M | 82.12M | (74.96M) | (11.68M) | (58.00M) | 4.54M | 19.20M | (2.34M) | (26.44M) | (27.75M) | (10.28M) | (4.19M) |
| FCF per Share | 3.81 | 2.14 | -1.98 | -0.32 | -1.62 | 0.13 | 0.53 | -0.07 | -0.87 | -2.31 | -0.42 | -0.17 |
| Book Value | 1.15B | 1.18B | 998.86M | 953.93M | 641.50M | 485.89M | 422.24M | 400.41M | 266.55M | 232.52M | (12.37M) | (8.06M) |
| Cash & ST Investments | 340.13M | 289.19M | 188.03M | 254.88M | 264.83M | 189.39M | 200.89M | 214.59M | 128.75M | 148.80M | 51.54M | 13.68M |
| ROC Equity | 0.01 | 0.08 | -0.00 | 0.01 | -0.02 | 0.10 | 0.02 | 0.01 | 0.06 | 0.01 | N/A | N/A |